mTORC1 Controls PNS Myelination along the mTORC1-RXRγ-SREBP-Lipid Biosynthesis Axis in Schwann Cells
Camilla Norrmén,
Gianluca Figlia,
Frédéric Lebrun-Julien,
Jorge A. Pereira,
Martin Trötzmüller,
Harald C. Köfeler,
Ville Rantanen,
Carsten Wessig,
Anne-Lieke F. van Deijk,
August B. Smit,
Mark H.G. Verheijen,
Markus A. Rüegg,
Michael N. Hall,
Ueli Suter
Affiliations
Camilla Norrmén
Institute of Molecular Health Sciences, Department of Biology, Swiss Federal Institute of Technology Zurich, ETH Zürich, CH-8093 Zurich, Switzerland
Gianluca Figlia
Institute of Molecular Health Sciences, Department of Biology, Swiss Federal Institute of Technology Zurich, ETH Zürich, CH-8093 Zurich, Switzerland
Frédéric Lebrun-Julien
Institute of Molecular Health Sciences, Department of Biology, Swiss Federal Institute of Technology Zurich, ETH Zürich, CH-8093 Zurich, Switzerland
Jorge A. Pereira
Institute of Molecular Health Sciences, Department of Biology, Swiss Federal Institute of Technology Zurich, ETH Zürich, CH-8093 Zurich, Switzerland
Martin Trötzmüller
Core Facility for Mass Spectrometry, Center for Medical Research, Medical University of Graz, 8010 Graz, Austria
Harald C. Köfeler
Core Facility for Mass Spectrometry, Center for Medical Research, Medical University of Graz, 8010 Graz, Austria
Ville Rantanen
Research Programs Unit, Genome-Scale Biology, and Institute of Biomedicine, Biochemistry and Developmental Biology, University of Helsinki, 00014 Helsinki, Finland
Carsten Wessig
Department of Neurology, University of Würzburg, 97080 Würzburg, Germany
Anne-Lieke F. van Deijk
Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Neuroscience Campus Amsterdam, VU University, 1081HV Amsterdam, the Netherlands
August B. Smit
Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Neuroscience Campus Amsterdam, VU University, 1081HV Amsterdam, the Netherlands
Mark H.G. Verheijen
Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Neuroscience Campus Amsterdam, VU University, 1081HV Amsterdam, the Netherlands
Markus A. Rüegg
Biozentrum, University of Basel, 4056 Basel, Switzerland
Michael N. Hall
Biozentrum, University of Basel, 4056 Basel, Switzerland
Ueli Suter
Institute of Molecular Health Sciences, Department of Biology, Swiss Federal Institute of Technology Zurich, ETH Zürich, CH-8093 Zurich, Switzerland
Myelin formation during peripheral nervous system (PNS) development, and reformation after injury and in disease, requires multiple intrinsic and extrinsic signals. Akt/mTOR signaling has emerged as a major player involved, but the molecular mechanisms and downstream effectors are virtually unknown. Here, we have used Schwann-cell-specific conditional gene ablation of raptor and rictor, which encode essential components of the mTOR complexes 1 (mTORC1) and 2 (mTORC2), respectively, to demonstrate that mTORC1 controls PNS myelination during development. In this process, mTORC1 regulates lipid biosynthesis via sterol regulatory element-binding proteins (SREBPs). This course of action is mediated by the nuclear receptor RXRγ, which transcriptionally regulates SREBP1c downstream of mTORC1. Absence of mTORC1 causes delayed myelination initiation as well as hypomyelination, together with abnormal lipid composition and decreased nerve conduction velocity. Thus, we have identified the mTORC1-RXRγ-SREBP axis controlling lipid biosynthesis as a major contributor to proper peripheral nerve function.